1/15
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
U.S. GAPP requires the disclosure of
Impairment losses
Allows reversals only on assets held for sale
Average age
Ending accumulated depreciation/ annual depreciation expense
Remaining useful life =
Ending net PP&E/ annual depreciation expense
Average age
Will not be found in the financial statement footnotes of a firm
Carrying value
OG cost- accumulated depreciation
upward revaluation
Increase bank value
Increase depreciation expense(in future periods, lowers net income)
Finite
End date
Cost of intangible assets is amortized if
The asset has a finite life and was purchased or acquired in business combo
Development cost
Are capitalized under IFRS, research cost are expenses as incurred
Development cost under US GAAP
Are capitalized once considered to be technically feasible and software intended for sale
Asset impairments cause
A loss on the I/s, has no impact on cash flows under IFRS
Under IFRS an asset is impaired when
Carrying value is greater than the recovery amount
Recovery amount is which ever is greater
1) Fair value(value in use) - selling cost
2) pv of expected cash flows
Under IFRS if an asset is impaired
it gets written down to the recoverable amount
Under U.S. GAAP an asset is impaired when
Carrying value is greater than assets undiscounted future cash flows
Under U.S. GAAP is an asset is impaired
It’s written down to its fair value